Skip to main content
. 2014 Dec 29;178(Suppl 1):67–69. doi: 10.1111/cei.12516

Figure 2.

Figure 2

Virus shedding after human rhinovirus (HRV) infection (reproduced from 15, copyright 2013 European Society of Clinical Microbiology and Infectious Diseases, with permission from John Wiley and Sons). The striking difference in the prolongation of duration of shedding of rhinovirus between immunocompetent children and adults alongside primary antibody-deficient patients on immunoglobulin (Ig) replacement therapy is shown.